New company Enzyvant takes aim at Farber disease
13 July 2016 | By Victoria White, Digital Content Producer
Enzyvant will focus on the development of recombinant human acid ceramidase (rhAC) for the treatment of patients with Farber disease...
List view / Grid view
13 July 2016 | By Victoria White, Digital Content Producer
Enzyvant will focus on the development of recombinant human acid ceramidase (rhAC) for the treatment of patients with Farber disease...
12 July 2016 | By Victoria White, Digital Content Producer
In a deal worth up to $528 million, Bayer and X-Chem are to collaborate to discovery therapies across multiple therapeutic areas and target classes...
12 July 2016 | By Victoria White, Digital Content Producer
Using gene therapy, scientists from Northwestern Medicine have identified a target in the brain that could lead to new treatments for depression...
12 July 2016 | By Victoria White, Digital Content Producer
Sorrento and Servier are teaming up to develop, manufacture and commercialise products using Sorrento's monoclonal antibody, STI-A1110...
11 July 2016 | By Victoria White, Digital Content Producer
Researchers from the University of Birmingham have revealed how a common condition called ‘MGUS’ can develop into myeloma...
11 July 2016 | By Victoria White, Digital Content Producer
An international project to develop a large, globally accessible, bank of new cancer models for the research community launches today...
10 July 2016 | By Cold Spring Harbor Laboratory
Researchers at Cold Spring Harbor Laboratory have discovered new insights into signalling events that underlie metastasis in ovarian cancer cells...
8 July 2016 | By Victoria White, Digital Content Producer
Scientists have identified the 'cell of origin' in basal cell carcinoma and followed the chain of events that lead to the growth of these invasive tumours...
8 July 2016 | By Victoria White, Digital Content Producer
Researchers were able to determine that Wars2 plays an important role in supplying sufficient endothelial cells for angiogenesis...
8 July 2016 | By Victoria White, Digital Content Producer
Scientists have employed a cutting-edge stem cell technique to unravel the mechanisms driving this phenomenon which affects some individuals with autism...
8 July 2016 | By Victoria White, Digital Content Producer
A study has found that let-7 plays a central role in curbing neuroblastoma and could focus efforts to find a targeted, nontoxic alternative to chemotherapy...
8 July 2016 | By Victoria White, Digital Content Producer
AdAlta is seeking to raise up to AU$10 million to fund clinical studies with its lead compound (AD-114) which shows promise in treating lung fibrosis...
7 July 2016 | By Victoria White, Digital Content Producer
Researchers have compared genetic mutations in tumours to those in cancer cell lines and then tested the cell lines' responses to therapeutic compounds...
6 July 2016 | By Victoria White, Digital Content Producer
The widely-used diabetes drug, metformin, reduced the toxic acid levels associated with MSUD in both skin cells derived from MSUD patients and in mice...
6 July 2016 | By Cold Spring Harbor Laboratory (CSHL)
Researchers have identified a new drug target in AML, created a candidate drug that hits the target and developed a new way of proving how the drug works...